Alexander Edward Kuta III - Jul 27, 2022 Form 4 Insider Report for uniQure N.V. (QURE)

Role
Executive VP, Operations
Signature
/s/ Christian Klemt, Attorney-in-Fact
Stock symbol
QURE
Transactions as of
Jul 27, 2022
Transactions value $
-$743,538
Form type
4
Date filed
7/29/2022, 01:39 PM
Previous filing
Jul 25, 2022
Next filing
Sep 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QURE Ordinary Shares Options Exercise $55.2K +10.4K +10.93% $5.31 106K Jul 27, 2022 Direct F1
transaction QURE Ordinary Shares Sale -$260K -10.4K -9.85% $25.00 95.2K Jul 27, 2022 Direct F1
transaction QURE Ordinary Shares Options Exercise $145K +27.4K +28.74% $5.31 123K Jul 28, 2022 Direct F1
transaction QURE Ordinary Shares Sale -$674K -27K -21.99% $25.00 95.6K Jul 28, 2022 Direct F1
transaction QURE Ordinary Shares Sale -$10.2K -406 -0.42% $25.01 95.2K Jul 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QURE Stock Option (Right to Buy) Options Exercise $0 -10.4K -27.55% $0.00 27.4K Jul 27, 2022 Ordinary Shares 10.4K $5.31 Direct F1, F2
transaction QURE Stock Option (Right to Buy) Options Exercise $0 -27.4K -100% $0.00* 0 Jul 28, 2022 Ordinary Shares 27.4K $5.31 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to a sales plan dated March 3, 2021 adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The Stock Option vested 25% on January 23, 2018 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.